https://www.indianpharmapost.com/roche-updates-on-sbla-for-columvi-combination-for-people-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-174422025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayers-nubeqa-receives-eu-approval-for-patients-with-advanced-prostate-cancer-174512025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/neuberg-pulse-partners-with-dhoni-to-launch-diagnostics-centre-in-ranchi-174502025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/imchecks-ict01-receives-fda-odd-for-treatment-of-acute-myeloid-leukemia-174492025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazenecas-tagrisso-plus-chemotherapy-improves-overall-survival-in-egfr-mutated-advanced-lung-cancer-174482025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/aarti-drugs-posts-q1-fy26-pat-higher-at-rs-54-cr-174472025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharmas-phase-3-cclinical-studies-for-tildrakizumab-100-mg-meet-primary-endpoint-174462025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/roche-provides-update-on-astegolimab-in-chronic-obstructive-pulmonary-disease-174452025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/miltenyi-biotec-and-thsti-partner-to-launch-car-t-cell-and-gene-therapy-training-curriculum-174442025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/sarepta-refuses-to-comply-with-fda-request-to-stop-shipping-gene-therapy-elevidys-174432025-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/biogen-to-invest-2-billion-to-expand-manufacturing-capability-in-north-carolina-174522025-07-21T00:00:00+05:30always0.9